LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Senti Biosciences (NASDAQ: SNTI)

Follow NASDAQ:SNTI Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SNTI Senti Biosciences
Celadon Partners SPV 24 / 10 percent owner
03/06/2025
Sell
$2.25
9.78M
$21.998M
0
NASDAQ SNTI Senti Biosciences
Celadon Partners SPV 24 / 10 percent owner
03/06/2025
Sell
$2.30
6.67M
$15.332M
0
NASDAQ SNTI Senti Biosciences
Mathers Edward T / director
03/07/2025
Buy
$3.52
43,900
$155K
43,900
NASDAQ SNTI Senti Biosciences
Rajangam Kanya / officer: Pres. & Chief Med. & Dev. Off.
03/10/2025
Buy
$2.25
33,000
$74K
33,000
NASDAQ SNTI Senti Biosciences
Rajangam Kanya / officer: Pres. & Chief Med. & Dev. Off.
03/10/2025
Sell
$2.25
33
$74
0
NASDAQ SNTI Senti Biosciences
Schulz Fran / director
03/07/2025
Buy
$3.52
43,900
$155K
43,900
NASDAQ SNTI Senti Biosciences
Collins James J. / director
03/07/2025
Buy
$3.52
43,900
$155K
43,900
NASDAQ SNTI Senti Biosciences
Tang Donald F / director
03/07/2025
Buy
$3.52
43,900
$155K
43,900
NASDAQ SNTI Senti Biosciences
COOPERSTONE BRENDA / director
03/07/2025
Buy
$3.52
43,900
$155K
43,900
NASDAQ SNTI Senti Biosciences
Hsiung Feng / director
03/07/2025
Buy
$3.52
43,900
$155K
43,900
NASDAQ SNTI Senti Biosciences
Cross John Harry III / officer: Chief Financial Officer
03/07/2025
Buy
$3.52
174,200
$613K
174,200
NASDAQ SNTI Senti Biosciences
Rajangam Kanya / officer: Pres. & Chief Med. & Dev. Off.
03/06/2025
Buy
$3.97
235,088
$933K
235,088
NASDAQ SNTI Senti Biosciences
Lu Timothy K / director, officer: CEO and Interim PFO and PAO
03/06/2025
Buy
$3.97
1.93M
$7.650M
1.93M

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous